Major trial tests if newer drugs can replace stem cell transplants for myeloma
Disease control
Ongoing
This study looked at 729 people with newly diagnosed multiple myeloma, aged up to 65. It compared a standard drug combination (lenalidomide, bortezomib, and dexamethasone) to the same drugs plus a stem cell transplant using the patient's own cells. The goal was to see if the tran…
Phase: PHASE3 • Sponsor: Paul Richardson, MD • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC